Halaman 3 - Melanoma Dokter Terbaik - TOP-98 dokter

Assoc. Prof. Nail Paksoy menggabungkan keahlian onkologi dengan penelitian imunoterapi di Rumah Sakit Medipol Bahçelievler.

• Sertifikasi ESMO Board dalam Onkologi Medis
• Sub-peneliti pada 8 uji klinis internasional utama
• Mempublikasikan penelitian tentang melanoma dan kanker lainnya
• Fellowship Onkologi Medis dari Universitas Istanbul

Spesialisasi dalam bedah laparoskopi dan bariatrik tingkat lanjut di Universitas Istanbul – salah satu institusi medis terkemuka di Turki.

• Lebih dari 20 tahun pengalaman bedah
• Terlatih di berbagai universitas bergengsi termasuk Ondokuz Mayıs dan Universitas Istanbul
• Menspesialisasi diri dalam teknik bedah kanker onkologi
• Menyelesaikan pelatihan bedah laparoskopi tingkat lanjut pada tahun 2010

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Alemdar berspesialisasi dalam pengobatan melanoma dengan pengalaman onkologi selama 7+ tahun di Rumah Sakit Universitas Akdeniz.

• Tersertifikasi dewan dalam onkologi medis
• Pelatihan ekstensif di Universitas Akdeniz – salah satu sekolah kedokteran terkemuka di Turki
• Praktik terfokus di Kompleks Rumah Sakit Medical Park Antalya
• Berpengalaman dalam kasus melanoma yang kompleks

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Senior Skin Cancer Fellow di St John's Institute of Dermatology – menempuh pelatihan di rumah sakit ternama di Inggris dan Israel, spesialisasi dalam melanoma.

• Fellowship di St John's Institute, pusat kanker kulit terkemuka
• Mengajar topik melanoma di King's College London
• Anggota European Academy of Dermatology and Venereology
• Spesialisasi dalam diagnosis dan tindakan bedah untuk kanker kulit

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Volkan Kinas berspesialisasi dalam bedah kanker, termasuk prosedur melanoma, di Rumah Sakit Büyük Anadolu.

• Keahlian dalam bedah onkologi dan payudara
• Ahli dalam bedah pankreas dan saluran empedu
• Melakukan bedah metabolik bariatrik dan diabetes

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Jesus Soberino berspesialisasi dalam imunoterapi melanoma, setelah berkontribusi pada uji klinis penting yang merevolusi pengobatan melanoma dengan obat-obatan seperti Pembrolizumab dan Nivolumab.

• 14 tahun pengalaman onkologi dengan fokus pada melanoma
• Anggota Unit Melanoma di Rumah Sakit Universitas Vall d'Hebron dan VHIO
• Berpartisipasi dalam uji klinis yang menghasilkan obat-obatan yang disetujui FDA
• Keahlian dalam perawatan imunoterapi untuk melanoma metastatik

Dr. Tepper memimpin seluruh Pusat Onkologi di Assuta Medical Center yang terkemuka di Israel, memberikan pengawasan strategis terhadap kasus-kasus melanoma yang kompleks.

• Kepala dokter dan onkolog senior dengan pengalaman terfokus selama bertahun-tahun
• Spesialisasi dalam penanganan tingkat lanjut untuk kanker kulit seperti melanoma
• Memberikan perawatan dalam jaringan rumah sakit swasta utama yang berteknologi tinggi
• Memberikan perspektif kepemimpinan dalam pembuatan rencana perawatan yang dipersonalisasi

Menekuni bidang radioterapi, Dr. Zalmanova menyediakan perawatan terukur di Assuta Medical Center.

• Menjadi ahli dalam teknik radioterapi tingkat lanjut
• Menyesuaikan rencana perawatan untuk setiap pasien
• Berfokus pada presisi dan kenyamanan pasien

Dr. Michael Lotem memimpin Pusat Imunoterapi Melanoma dan Kanker di Hadassah Medical Center, merintis perawatan baru bagi pasien melanoma.

• Kepala Pusat Imunoterapi Melanoma dan Kanker
• Spesialisasi dalam imunoterapi inovatif untuk melanoma
• Memimpin tim klinisi dan peneliti
• Fokus pada penelitian translasi dengan dampak klinis langsung

Dr. Bar-Sela adalah Wakil Kepala Departemen Onkologi di Rambam Medical Center.

• Memimpin tim khusus di dalam rumah sakit akademik utama
• Berfokus pada pengobatan melanoma
• Mengawasi program pengobatan lanjutan bagi pasien kanker